HIF1A and neoplasm: HIF-1α promotes the upregulation of glycolytic enzymes and mono-carboxylate transporters (MCT-4) in CAA/CAFs, thereby increasing the production and transportation of mono-carboxylates (lactate, pyruvate, beta-hydroxy butyrate (β-HB)) into the tumour microenvironment.